The effect of COVID-19 pandemic on diabetes care indices in Southern Iran: an interrupted time series analysis.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
13 Feb 2023
Historique:
received: 17 10 2021
accepted: 07 02 2023
entrez: 14 2 2023
pubmed: 15 2 2023
medline: 16 2 2023
Statut: epublish

Résumé

Type 2 diabetes mellitus (T2DM) requires a continues bulk of cares. It is very probable COVID-19 pandemic is affected its healthcare coverage. The interrupted time series analysis is used to model the trend of diabetes healthcare indices, such as the health worker visits, physician visits, body mass index (MBI), fasting blood sugar (FBS), and hemoglobin A1c (HbA1c), before and after the start of COVID-19 pandemic. The reference of data was the totals of all T2DM patients living in Fars Province, Southern Iran, areas covered by Shiraz University of Medical Science (SUMS), from 2019 to 2020. A significant decrease for visits by the health workers, and physicians was observed by starting COVID-19 pandemic (β When the COVID-19 pandemic was announced, T2DM healthcare coverage drastically decreased, but it quickly began to rebound. The health monitoring system could not have any noticeable effects on diabetes outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Type 2 diabetes mellitus (T2DM) requires a continues bulk of cares. It is very probable COVID-19 pandemic is affected its healthcare coverage.
METHODS METHODS
The interrupted time series analysis is used to model the trend of diabetes healthcare indices, such as the health worker visits, physician visits, body mass index (MBI), fasting blood sugar (FBS), and hemoglobin A1c (HbA1c), before and after the start of COVID-19 pandemic. The reference of data was the totals of all T2DM patients living in Fars Province, Southern Iran, areas covered by Shiraz University of Medical Science (SUMS), from 2019 to 2020.
RESULTS RESULTS
A significant decrease for visits by the health workers, and physicians was observed by starting COVID-19 pandemic (β
CONCLUSIONS CONCLUSIONS
When the COVID-19 pandemic was announced, T2DM healthcare coverage drastically decreased, but it quickly began to rebound. The health monitoring system could not have any noticeable effects on diabetes outcomes.

Identifiants

pubmed: 36782171
doi: 10.1186/s12913-023-09158-4
pii: 10.1186/s12913-023-09158-4
pmc: PMC9925215
doi:

Substances chimiques

Glycated Hemoglobin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

148

Informations de copyright

© 2023. The Author(s).

Références

J Gen Intern Med. 2021 May;36(5):1460-1462
pubmed: 33469742
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3
pubmed: 32369736
JMIR Diabetes. 2020 May 15;5(2):e19581
pubmed: 32392473
Arch Iran Med. 2020 Aug 01;23(8):564-567
pubmed: 32894970
BMJ Open Diabetes Res Care. 2018 Dec 06;6(1):e000541
pubmed: 30613400
Obes Med. 2022 Aug;33:100418
pubmed: 35664969
Acad Pediatr. 2013 Nov-Dec;13(6 Suppl):S38-44
pubmed: 24268083
Diabetes Care. 2021 Jan;44(1):e18-e21
pubmed: 33127611
Diabetes Care. 2003 Jan;26 Suppl 1:S33-50
pubmed: 12502618
Diabetes Res Clin Pract. 2021 Jun;176:108840
pubmed: 33933499
Diabetes Res Clin Pract. 2020 Aug;166:108304
pubmed: 32623040
Diabetes Obes Metab. 2021 Jul;23(7):1624-1630
pubmed: 33764666
BMJ Open. 2014 Apr 17;4(4):e004100
pubmed: 24742975
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1815-1819
pubmed: 32956926
Iran J Med Sci. 2019 May;44(3):204-213
pubmed: 31182886
BMC Public Health. 2011 Jul 14;11:564
pubmed: 21756350
Heliyon. 2021 Jun 09;7(6):e07260
pubmed: 34179534
Lancet. 2011 Jul 2;378(9785):31-40
pubmed: 21705069
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1579-1584
pubmed: 32858476
Diabetes Care. 2020 Jul;43(7):1399-1407
pubmed: 32409498
Prim Care Diabetes. 2021 Dec;15(6):918-922
pubmed: 34393092
BMJ Open. 2022 Oct 26;12(10):e059983
pubmed: 36288832
J Adolesc Health. 2020 Oct;67(4):615-617
pubmed: 32798101
Prim Care Diabetes. 2021 Jun;15(3):424-427
pubmed: 33441263
Eur J Endocrinol. 2020 Aug;183(2):G67-G77
pubmed: 32508313
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):965-967
pubmed: 32604016

Auteurs

Alireza Mirahmadizadeh (A)

Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Mohammad Hossein Sharifi (MH)

Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Jafar Hassanzadeh (J)

Research Center for Health Sciences, Institute of Health, School of Health, Department of Epidemiology, Shiraz University of Medical Sciences, Shiraz, Iran.

Alireza Heiran (A)

Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Fariba Moradi Ardekani (FM)

Non-Communicable Diseases Group Manager, Office of Vice Chancellor for Health Affairs, Shiraz University of Medical Sciences, Shiraz, Iran.

Neda Hadizadeh (N)

Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Mehdi Sharafi (M)

Student Research Committee, Shiraz University of Medical Sciences, School of Health, Shiraz, Iran.
Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.

Mohammad Mohammadi Abnavi (MM)

Student Research Committee, Shiraz University of Medical Sciences, School of Health, Shiraz, Iran. afshinmohammadi295@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH